Which closed-end funds own Contra Mirati Therapeu?
3 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $160K. Security type: OTHER. Country: United States. CUSIP 604CVR027 · ISIN US604CVR0279 · ticker MRTX.
Holdings are historical filings (report dates Jun 30, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| BMEZ BlackRock Health Sciences Term Trust | Healthcare | 0.01% | $142K | 180,175 sh | $1.1B | NAV unavailable | Jun 30, 2026 |
| GDL GDL Fund | U.S. Equity | 0.00% | $5K | 10,000 sh | $122M | 21.3% discount | Jun 30, 2026 |
| BME BlackRock Health Sciences Trust | Healthcare | 0.00% | $12.4K | 15,747 sh | $573M | 2.8% discount | Jun 30, 2026 |
3 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Also listed in filings as: MIRATI THERAPEUTICS INC.
Issuer-level search for “MRTX” → · Compare two funds’ portfolios →